HealthHCV Logo

Buprenorphine Implementation for Opioid Use Disorder Treatment

Access This Resource
Date Added
August 8, 2021
Resource Type
Subject Areas
Associated Programs

The Implementing Transmucosal Buprenorphine for Treatment of Opioid Use Disorder best practice document was designed to fill information gaps and provide guidance.

Related Resources

HCV Universal Screening Guidelines Webinar

This recording of a presentation by CDC’s Dr. Sarah Schillie explores CDC’s newest HCV screening recommendations.

View Resource

Opioids and Hepatitis C

This presentation from the SYNChronicity conference examines the effects of opioid use on HCV.

View Resource

HealthHCV

An Initiative of HealthHIV

1630 Connecticut Ave. NW, Suite 500
Washington, DC 20009

202-232-6749 | [email protected]

Main Menu
Learning Advocacy Research & Evaluation About HealthHCV
Other HealthHIV Initiatives
National Coalition for LGBTQ Health PleasePrEPMe.org SYNChronicity Conference

© Copyright 2025 HealthHIV. All rights reserved. | Privacy Policy | Site Map